6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
8 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05568498
(ClinicalTrials.gov)		October 30, 202215/6/2022Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's DiseaseProbiotic Treatment for Depression and Associated Mood Disorders in Parkinson's DiseaseParkinson Disease;DepressionDietary Supplement: Probiotic;Dietary Supplement: PlaceboUniversity of British ColumbiaNULLNot yet recruiting40 Years80 YearsAll60Phase 2NULL
2NCT05173701
(ClinicalTrials.gov)		November 22, 20218/11/2021Effects of Probiotics on Peripheral Immunity in Parkinson's DiseaseEffects of Probiotics on Peripheral Immunity in Parkinson's DiseaseParkinson's DiseaseDietary Supplement: Probiotics;Dietary Supplement: PlaceboFranca MarinoUniversità degli Studi del Piemonte Orientale Amedeo Avogadro;Università degli Studi dell'InsubriaEnrolling by invitationN/AN/AAll88N/AItaly
3NCT04871464
(ClinicalTrials.gov)		November 11, 202129/4/2021Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's DiseaseRole and Mechanism of Bifidobacterium Triple Viable Capsules in Improving Motor Symptoms in Patients With Mild to Moderate Parkinson's Disease: a Multicenter Randomized Clinical StudyParkinson Disease;Parkinsonian Disorders;Basal Ganglia Diseases;Brain Diseases;Movement Disorders;Neurodegenerative Diseases;Central Nervous System Diseases;Nervous System DiseasesDrug: Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules;Other: PlaceboBeijing Friendship HospitalNULLRecruiting40 Years85 YearsAll240Phase 4China
4NCT03968133
(ClinicalTrials.gov)		December 10, 202028/5/2019Treating Anxiety in Parkinson's Disease With a Multi-Strain ProbioticTreating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic - a Randomized, Placebo-controlled TrialParkinson Disease;AnxietyDietary Supplement: Probiotic;Dietary Supplement: PlaceboUniversity of British ColumbiaThe W. Garfield Weston FoundationRecruiting40 Years80 YearsAll72Phase 2Canada
5NCT05146921
(ClinicalTrials.gov)		July 4, 20192/11/2021Gut Health and Probiotics in Parkinson's (SymPD)Gut Health and Probiotics in Parkinson's (SymPD)Parkinson DiseaseDietary Supplement: Multi-strain probiotic;Other: PlaceboKing's College Hospital NHS TrustKing's College LondonActive, not recruiting18 YearsN/AAll60N/AUnited Kingdom
6NCT04293159
(ClinicalTrials.gov)		May 14, 201919/2/2020Effect of Probiotic on Constipation in Patients With Parkinson's DiseaseEffect of Probiotic on Constipation and on Neuropsychological Performance in Patients With Parkinson's DiseaseParkinson Disease;ConstipationDietary Supplement: Lactobacillus casei DG (Enterolactis duo®)University of SalernoRoberto Erro;Maria Teresa Pellecchia;Antonella Santonicola;Carolina CiacciRecruiting18 Years75 YearsAll30N/AItaly
7NCT04451096
(ClinicalTrials.gov)		October 6, 201819/6/2020Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With ConstipationProbiotics-prebiotic Fiber Therapy Improved Bowel Opening Frequency and Whole Gut Transit Time in Parkinson's Disease Patients With Constipation: A Randomised Controlled StudyParkinson Disease;ConstipationDietary Supplement: Probiotics with prebiotic;Dietary Supplement: PlaceboNational University of MalaysiaNULLCompleted18 YearsN/AAll48Phase 3Malaysia
8NCT03377322
(ClinicalTrials.gov)		December 1, 20177/12/2017Trial of Probiotics for Constipation in Parkinson's DiseaseA Randomized Double-Blinded Placebo-Controlled Trial of Probiotics for Constipation in Parkinson's DiseaseParkinson DiseaseDrug: Probiotic Capsule;Drug: Placebo CapsuleUniversity of MalayaNULLCompleted40 Years85 YearsAll72N/AMalaysia

Back to top